J Gastroenterol Hepatol. 2007;22(9):1423-1428. The diagnosis of gastroparesis was not made in any of our patients, despite severe symptoms, until they were referred to adult or pediatric ...
Renexxion, Inc. is a clinical-stage biopharmaceutical company pioneering therapies for gastrointestinal (GI) disorders. Renexxion’s lead compound, naronapride, is a potential best-in-class, highly ...
Autonomous AI agents inhabit virtual worlds, shaping economies, solving challenges, and driving ... [+] innovation—showing us a future where machines collaborate and create without human ...
Renexxion’s lead compound, naronapride, is a potential best-in-class, highly selective dual-action 5-HT4 agonist/D2-antagonist prokinetic agent designed to enhance GI motility with minimal systemic ...
Renexxion's lead compound, naronapride, is a potential best-in-class, highly selective dual-action 5-HT4 agonist/D2-antagonist prokinetic agent designed to enhance GI motility with minimal systemic ...
Pro Football Focus put out their ranking of the 50 best free agents for the 2025 offseason this week. The Pittsburgh Steelers landed five players on the list including both of the team’s top ...